160 related articles for article (PubMed ID: 27518102)
1. Changes in Pre- and Post-Exercise Gene Expression among Patients with Chronic Kidney Disease and Kidney Transplant Recipients.
Coletta DK; Campbell LE; Weil J; Kaplan B; Clarkson M; Finlayson J; Mandarino LJ; Chakkera HA
PLoS One; 2016; 11(8):e0160327. PubMed ID: 27518102
[TBL] [Abstract][Full Text] [Related]
2. Impaired insulin-stimulated nonoxidative glucose metabolism in pancreas-kidney transplant recipients. Dose-response effects of insulin on glucose turnover.
Christiansen E; Vestergaard H; Tibell A; Hother-Nielsen O; Holst JJ; Pedersen O; Madsbad S
Diabetes; 1996 Sep; 45(9):1267-75. PubMed ID: 8772733
[TBL] [Abstract][Full Text] [Related]
3. Monitoring of calcineurin inhibitors by NFAT-regulated gene expression in de novo renal allograft recipients on cyclosporine A.
Sommerer C; Zeier M; Meuer S; Giese T
Clin Nephrol; 2015 Sep; 84(3):165-72. PubMed ID: 26226950
[TBL] [Abstract][Full Text] [Related]
4. Ca
Luo P; Wang L; Luo L; Wang L; Yang K; Shu G; Wang S; Zhu X; Gao P; Jiang Q
Food Funct; 2019 Aug; 10(8):5166-5173. PubMed ID: 31378798
[TBL] [Abstract][Full Text] [Related]
5. Developmental regulation of the mouse IGF-I exon 1 promoter region by calcineurin activation of NFAT in skeletal muscle.
Alfieri CM; Evans-Anderson HJ; Yutzey KE
Am J Physiol Cell Physiol; 2007 May; 292(5):C1887-94. PubMed ID: 17229811
[TBL] [Abstract][Full Text] [Related]
6. Conversion from Tacrolimus to Cyclosporine A Improves Glucose Tolerance in HCV-Positive Renal Transplant Recipients.
Handisurya A; Kerscher C; Tura A; Herkner H; Payer BA; Mandorfer M; Werzowa J; Winnicki W; Reiberger T; Kautzky-Willer A; Pacini G; Säemann M; Schmidt A
PLoS One; 2016; 11(1):e0145319. PubMed ID: 26735686
[TBL] [Abstract][Full Text] [Related]
7. Correlation between pharmacokinetics of tacrolimus and pharmacodynamics on NFAT-regulated gene expression in stable kidney transplant recipients
.
Keller F; Sommerer C; Giese T; Zeier M; Schröppel B
Clin Nephrol; 2017 Feb; 87 (2017)(2):93-99. PubMed ID: 28025957
[TBL] [Abstract][Full Text] [Related]
8. Individualized monitoring of nuclear factor of activated T cells-regulated gene expression in FK506-treated kidney transplant recipients.
Sommerer C; Zeier M; Meuer S; Giese T
Transplantation; 2010 Jun; 89(11):1417-23. PubMed ID: 20463649
[TBL] [Abstract][Full Text] [Related]
9. Effect of moderate acute exercise on expression of mRNA involved in the calcineurin signaling pathway in human skeletal muscle.
Hitomi Y; Kizaki T; Katsumura T; Mizuno M; Itoh CE; Esaki K; Fujioka Y; Takemasa T; Haga S; Ohno H
IUBMB Life; 2003 Jul; 55(7):409-13. PubMed ID: 14584592
[TBL] [Abstract][Full Text] [Related]
10. IRS-1 serine phosphorylation and insulin resistance in skeletal muscle from pancreas transplant recipients.
Bouzakri K; Karlsson HK; Vestergaard H; Madsbad S; Christiansen E; Zierath JR
Diabetes; 2006 Mar; 55(3):785-91. PubMed ID: 16505244
[TBL] [Abstract][Full Text] [Related]
11. Analysis of NFAT-regulated gene expression in vivo: a novel perspective for optimal individualized doses of calcineurin inhibitors.
Giese T; Zeier M; Meuer S
Nephrol Dial Transplant; 2004 Jul; 19 Suppl 4():iv55-60. PubMed ID: 15240851
[TBL] [Abstract][Full Text] [Related]
12. Differentially expressed gene transcripts using RNA sequencing from the blood of immunosuppressed kidney allograft recipients.
Dorr C; Wu B; Guan W; Muthusamy A; Sanghavi K; Schladt DP; Maltzman JS; Scherer SE; Brott MJ; Matas AJ; Jacobson PA; Oetting WS; Israni AK
PLoS One; 2015; 10(5):e0125045. PubMed ID: 25946140
[TBL] [Abstract][Full Text] [Related]
13. Nuclear Factor of Activated T Cells-Regulated Gene Expression as Predictive Biomarker of Personal Response to Calcineurin Inhibitors.
Sommerer C; Giese T
Ther Drug Monit; 2016 Apr; 38 Suppl 1():S50-6. PubMed ID: 26418701
[TBL] [Abstract][Full Text] [Related]
14. Pharmacodynamic monitoring of nuclear factor of activated T cell-regulated gene expression in liver allograft recipients on immunosuppressive therapy with calcineurin inhibitors in the course of time and correlation with acute rejection episodes--a prospective study.
Steinebrunner N; Sandig C; Sommerer C; Hinz U; Giese T; Stremmel W; Zahn A
Ann Transplant; 2014 Jan; 19():32-40. PubMed ID: 24457606
[TBL] [Abstract][Full Text] [Related]
15. Insulin-stimulated muscle glucose clearance in patients with NIDDM. Effects of one-legged physical training.
Dela F; Larsen JJ; Mikines KJ; Ploug T; Petersen LN; Galbo H
Diabetes; 1995 Sep; 44(9):1010-20. PubMed ID: 7657022
[TBL] [Abstract][Full Text] [Related]
16. Early steroid withdrawal therapy in renal transplant recipients: a steroid-free sirolimus and CellCept-based calcineurin inhibitor-minimization protocol.
Jaber JJ; Feustel PJ; Elbahloul O; Conti AD; Gallichio MH; Conti DJ
Clin Transplant; 2007; 21(1):101-9. PubMed ID: 17302598
[TBL] [Abstract][Full Text] [Related]
17. The Calcineurin Inhibitor-Sparing (CIS) Trial - individualised calcineurin-inhibitor treatment by immunomonitoring in renal allograft recipients: protocol for a randomised controlled trial.
Sommerer C; Schaier M; Morath C; Schwenger V; Rauch G; Giese T; Zeier M
Trials; 2014 Dec; 15():489. PubMed ID: 25494823
[TBL] [Abstract][Full Text] [Related]
18. Ciclosporin A tapering monitored by NFAT-regulated gene expression: a new concept of individual immunosuppression.
Sommerer C; Giese T; Schmidt J; Meuer S; Zeier M
Transplantation; 2008 Jan; 85(1):15-21. PubMed ID: 18192906
[TBL] [Abstract][Full Text] [Related]
19. Glucose metabolism in renal transplant recipients: effect of calcineurin inhibitor withdrawal and conversion to sirolimus.
Teutonico A; Schena PF; Di Paolo S
J Am Soc Nephrol; 2005 Oct; 16(10):3128-35. PubMed ID: 16107580
[TBL] [Abstract][Full Text] [Related]
20. Effects of a Structured Physical Activity Program on Serum Adipokines and Markers of Inflammation and Volume Overload in Kidney Transplant Recipients.
Muras-Szwedziak K; Masajtis-Zagajewska A; Pawłowicz E; Nowicki M
Ann Transplant; 2019 Oct; 24():569-575. PubMed ID: 31591375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
